Work

Phase I study of the oral GLP ‐1 receptor agonist DA ‐ 302168S : Safety, pharmacokinetics, and pharmacodynamics in healthy and overweight/obese adults

FWCI: 1.939
Cites: 22
Cited by: 4
Related to: